NLPHL patient characteristics
| No. patients | 15 |
| Median age, y (range) | 39 (23-49) |
| Male, no (%) | 13 (87) |
| Ann Arbor stage | |
| I/II | 9 |
| III/IV | 6 |
| Prior therapy | |
| Radiation | 7 |
| Radiation and chemotherapy | 3 |
| Chemotherapy | 3 |
| Chemotherapy and splenectomy | 1 |
| Chemotherapy, splenectomy, and radiation | 1 |
| Time since first diagnosis | |
| Less than 1 year | 1 |
| 1 to 5 years | 2 |
| More than 5 years | 12 |
| Number of relapses | |
| 1 | 8 |
| 2 | 4 |
| 3 | 3 |
| Response to treatment | |
| Stage I/II A/B, no. (%) (n = 9) | |
| ORR* | 9 (100)* |
| CR | 5 (56) |
| PR | 4 (44) |
| PD | 0 |
| Stage III/IV A/B, no. (%) (n = 6) | |
| ORR* | 5 (83)* |
| CR | 3 (50) |
| PR | 2 (33) |
| PD | 1 (17) |
| No. patients | 15 |
| Median age, y (range) | 39 (23-49) |
| Male, no (%) | 13 (87) |
| Ann Arbor stage | |
| I/II | 9 |
| III/IV | 6 |
| Prior therapy | |
| Radiation | 7 |
| Radiation and chemotherapy | 3 |
| Chemotherapy | 3 |
| Chemotherapy and splenectomy | 1 |
| Chemotherapy, splenectomy, and radiation | 1 |
| Time since first diagnosis | |
| Less than 1 year | 1 |
| 1 to 5 years | 2 |
| More than 5 years | 12 |
| Number of relapses | |
| 1 | 8 |
| 2 | 4 |
| 3 | 3 |
| Response to treatment | |
| Stage I/II A/B, no. (%) (n = 9) | |
| ORR* | 9 (100)* |
| CR | 5 (56) |
| PR | 4 (44) |
| PD | 0 |
| Stage III/IV A/B, no. (%) (n = 6) | |
| ORR* | 5 (83)* |
| CR | 3 (50) |
| PR | 2 (33) |
| PD | 1 (17) |
ORR indicates overall response rate; CR, complete remission; PR, partial remission; PD, progressive disease, —, no data.
indicates percentage.